ChEMBL web services: streamlining access to drug discovery data and utilities
- PMID: 25883136
- PMCID: PMC4489243
- DOI: 10.1093/nar/gkv352
ChEMBL web services: streamlining access to drug discovery data and utilities
Abstract
ChEMBL is now a well-established resource in the fields of drug discovery and medicinal chemistry research. The ChEMBL database curates and stores standardized bioactivity, molecule, target and drug data extracted from multiple sources, including the primary medicinal chemistry literature. Programmatic access to ChEMBL data has been improved by a recent update to the ChEMBL web services (version 2.0.x, https://www.ebi.ac.uk/chembl/api/data/docs), which exposes significantly more data from the underlying database and introduces new functionality. To complement the data-focused services, a utility service (version 1.0.x, https://www.ebi.ac.uk/chembl/api/utils/docs), which provides RESTful access to commonly used cheminformatics methods, has also been concurrently developed. The ChEMBL web services can be used together or independently to build applications and data processing workflows relevant to drug discovery and chemical biology.
© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.
Figures
Similar articles
-
The ChEMBL database in 2017.Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. doi: 10.1093/nar/gkw1074. Epub 2016 Nov 28. Nucleic Acids Res. 2017. PMID: 27899562 Free PMC article.
-
Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.Expert Opin Drug Discov. 2017 Aug;12(8):757-767. doi: 10.1080/17460441.2017.1339032. Epub 2017 Jun 12. Expert Opin Drug Discov. 2017. PMID: 28602100 Free PMC article. Review.
-
The ChEMBL bioactivity database: an update.Nucleic Acids Res. 2014 Jan;42(Database issue):D1083-90. doi: 10.1093/nar/gkt1031. Epub 2013 Nov 7. Nucleic Acids Res. 2014. PMID: 24214965 Free PMC article.
-
ChEMBL: a large-scale bioactivity database for drug discovery.Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7. doi: 10.1093/nar/gkr777. Epub 2011 Sep 23. Nucleic Acids Res. 2012. PMID: 21948594 Free PMC article.
-
Web tools for predictive toxicology model building.Expert Opin Drug Metab Toxicol. 2012 Jul;8(7):791-801. doi: 10.1517/17425255.2012.685158. Epub 2012 May 12. Expert Opin Drug Metab Toxicol. 2012. PMID: 22577953 Review.
Cited by
-
Generalizability Improvement of Interpretable Symbolic Regression Models for Quantitative Structure-Activity Relationships.ACS Omega. 2024 Feb 16;9(8):9463-9474. doi: 10.1021/acsomega.3c09047. eCollection 2024 Feb 27. ACS Omega. 2024. PMID: 38434845 Free PMC article.
-
In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases.Int J Alzheimers Dis. 2024 Feb 8;2024:2988685. doi: 10.1155/2024/2988685. eCollection 2024. Int J Alzheimers Dis. 2024. PMID: 38371416 Free PMC article.
-
The pursuit of accurate predictive models of the bioactivity of small molecules.Chem Sci. 2024 Jan 12;15(6):1938-1952. doi: 10.1039/d3sc05534e. eCollection 2024 Feb 7. Chem Sci. 2024. PMID: 38332817 Free PMC article. Review.
-
A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel.Front Pharmacol. 2024 Jan 24;14:1251061. doi: 10.3389/fphar.2023.1251061. eCollection 2023. Front Pharmacol. 2024. PMID: 38328578 Free PMC article. Review.
-
The Pivotal Distinction between Antagonists' and Agonists' Binding into Dopamine D4 Receptor-MD and FMO/PIEDA Studies.Int J Mol Sci. 2024 Jan 6;25(2):746. doi: 10.3390/ijms25020746. Int J Mol Sci. 2024. PMID: 38255820 Free PMC article.
References
-
- Davies M., Nowotka M., Papadatos G., Atkinson F., van Westen G.J., Dedman N., Ochoa R., Overington J.P. MyChEMBL: a virtual platform for distributing cheminformatics tools and Open Data. Challenges. 2014;5:334–337.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
